1444 POSTER Evaluation of Hand-foot Syndrome (HFS) as a Potential Biomarker of Sunitinib (SU) Efficacy in Patients (pts) With Metastatic Renal Cell Carcinoma (mRCC) and Gastrointestinal Stromal Tumour (GIST)
I. Puzanov, D. Michaelson, D. Cohen, S. Li, P. Burnett, J. DesaiVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70937-6
File:
PDF, 42 KB
english, 2011